Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag.
作者信息
Fattizzo Bruno, Kulasekararaj Austin G, Hill Anita, Benson-Quarm Nana, Griffin Morag, Munir Talha, Arnold Louise, Riley Kathryn, Ireland Robin, De Lavallade Hugues, Potter Victoria, Consonni Dario, Hillmen Peter, Mufti Ghulam J, Barcellini Wilma, Marsh Judith C W
机构信息
Haematology, King's College Hospital, London, UK.
Haematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
出版信息
Haematologica. 2019 Nov;104(11):e494-e496. doi: 10.3324/haematol.2019.216374. Epub 2019 Mar 19.
Abstract
摘要
相似文献
1
Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag.
Haematologica. 2019 Nov;104(11):e494-e496. doi: 10.3324/haematol.2019.216374. Epub 2019 Mar 19.
2
Efficacy and Safety of Eltrombopag for Aplastic Anemia: A Systematic Review and Meta-analysis.
Clin Drug Investig. 2019 Feb;39(2):141-156. doi: 10.1007/s40261-018-0725-2.
3
Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.
Hematology. 2018 Aug;23(7):399-404. doi: 10.1080/10245332.2017.1422306. Epub 2018 Jan 5.
4
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.
Blood. 2014 Mar 20;123(12):1818-25. doi: 10.1182/blood-2013-10-534743. Epub 2013 Dec 17.
5
[Safety and efficacy of the use of eltrombopag in a case of severe acquired bone marrow aplasia].
An Pediatr (Engl Ed). 2019 Apr;90(4):246-247. doi: 10.1016/j.anpedi.2018.04.011. Epub 2018 May 22.
6
Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
N Engl J Med. 2012 Jul 5;367(1):11-9. doi: 10.1056/NEJMoa1200931.
7
Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.
Ann Hematol. 2019 Aug;98(8):2009-2011. doi: 10.1007/s00277-019-03658-2. Epub 2019 Mar 20.
8
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome: From Megakaryopoiesis to Immunomodulation.
Drugs. 2019 Aug;79(12):1305-1319. doi: 10.1007/s40265-019-01159-0.
9
Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
Cancer. 2018 Nov 1;124(21):4192-4201. doi: 10.1002/cncr.31658. Epub 2018 Oct 11.
10
A rare side effect: eltrombopag associated hyperpigmentation.
G Ital Dermatol Venereol. 2020 Dec;155(6):803-804. doi: 10.23736/S0392-0488.19.06181-9. Epub 2019 May 14.
引用本文的文献
1
Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study.
Ann Med. 2025 Dec;57(1):2514791. doi: 10.1080/07853890.2025.2514791. Epub 2025 Jun 19.
2
Determinants of COVID-19 Disease Severity-Lessons from Primary and Secondary Immune Disorders including Cancer.
Int J Mol Sci. 2023 May 14;24(10):8746. doi: 10.3390/ijms24108746.
3
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.
Int J Mol Sci. 2022 Oct 4;23(19):11765. doi: 10.3390/ijms231911765.
4
Paroxysmal nocturnal hemoglobinuria-phenotype cells predict a good response to eltrombopag in patients with refractory aplastic anemia.
EJHaem. 2020 Jun 29;1(1):243-248. doi: 10.1002/jha2.51. eCollection 2020 Jul.
5
Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag.
Front Immunol. 2022 May 26;13:884312. doi: 10.3389/fimmu.2022.884312. eCollection 2022.
6
Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
Ann Hematol. 2021 Oct;100(10):2435-2441. doi: 10.1007/s00277-021-04553-5. Epub 2021 Jul 16.
7
Exosomes derived from mesenchymal stem cells regulate Treg/Th17 balance in aplastic anemia by transferring miR-23a-3p.
Clin Exp Med. 2021 Aug;21(3):429-437. doi: 10.1007/s10238-021-00701-3. Epub 2021 Mar 29.
8
Correlation of the Plasma Concentration of Eltrombopag With Efficacy in the Treatment of Refractory Aplastic Anemia: A Single-Centre Study in China.
Front Pharmacol. 2020 Nov 16;11:582625. doi: 10.3389/fphar.2020.582625. eCollection 2020.
9
Novel therapeutic choices in immune aplastic anemia.
F1000Res. 2020 Sep 10;9. doi: 10.12688/f1000research.22214.1. eCollection 2020.
10
Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
Ann Hematol. 2020 Dec;99(12):2755-2761. doi: 10.1007/s00277-020-04266-1. Epub 2020 Sep 17.
本文引用的文献
1
Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.
Haematologica. 2018 Feb;103(2):212-220. doi: 10.3324/haematol.2017.176339. Epub 2017 Nov 23.
2
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011.
Haematologica. 2017 Oct;102(10):1683-1690. doi: 10.3324/haematol.2017.169862. Epub 2017 Jul 27.
3
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
N Engl J Med. 2017 Apr 20;376(16):1540-1550. doi: 10.1056/NEJMoa1613878.
4
Guidelines for the diagnosis and management of adult aplastic anaemia.
Br J Haematol. 2016 Jan;172(2):187-207. doi: 10.1111/bjh.13853. Epub 2015 Nov 16.
5
6
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.
Blood. 2014 Mar 20;123(12):1818-25. doi: 10.1182/blood-2013-10-534743. Epub 2013 Dec 17.
7
Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
N Engl J Med. 2012 Jul 5;367(1):11-9. doi: 10.1056/NEJMoa1200931.
8
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.
Blood. 2012 Jun 7;119(23):5391-6. doi: 10.1182/blood-2012-02-407684. Epub 2012 Apr 27.
9
Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells.
Cell Stem Cell. 2007 Dec 13;1(6):671-84. doi: 10.1016/j.stem.2007.10.008. Epub 2007 Nov 20.
10
Zotero 插件